검체 채취 카드 시장 규모, 점유율, 동향 분석 보고서 : 검체 유형별, 재료별, 제품별, 용도별, 유통 채널별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Specimen Collection Cards Market Growth & Trends:

The global specimen collection cards market size is expected to reach USD 621.3 million by 2030, registering a CAGR of 5.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is expected to register promising growth owing to the increasing emphasis on non-invasive procedures, favorable government policies for newborn screening, and increasing investments in research & development. Moreover, ease of use and cost-effectiveness of the products is also likely to have a positive impact on the market growth.

The market is experiencing significant growth due to the increasing focus on personalized medicine, genetic testing, health monitoring, and well-being initiatives. Personalized medicine aims to customize medical treatments based on individual genetic profiles, lifestyle factors, and other relevant information. Genetic testing plays a vital role in this approach by providing insights into an individual's genetic makeup, enabling personalized diagnostics, treatment selection, and disease prevention strategies. Specimen collection cards have become essential tools in genetic testing processes, offering a convenient and reliable method for collecting various biological samples, such as saliva, blood, and tissue.

Moreover, specimen collection cards contribute to health monitoring and well-being programs by enabling the collection of biomarkers & analytes that provide valuable information about an individual's health status and overall well-being. These cards are used in kits designed for monitoring hormone levels, detecting infectious diseases, and measuring key biomarkers related to chronic conditions like diabetes or cardiovascular diseases.

The ease of sample collection using specimen collection cards promotes regular monitoring, facilitating early detection of health issues and timely interventions, ultimately leading to improved health outcomes. The growing emphasis on personalized medicine, genetic testing, health monitoring, and well-being initiatives is driving the demand for specimen collection cards in the market. These cards provide a practical solution by offering a versatile and user-friendly platform for collecting various biological samples, empowering individuals to take control of their health. The integration of specimen collection cards into innovative genetic testing kits and health monitoring solutions further solidifies their role in supporting personalized medicine and enabling individuals to make well-informed decisions about their health & well-being.

Key players operating in the industry are focusing on raising funds to excel in their research and development activities along with other inorganic and organic strategies. For instance, in June 2022, OrisDX received funding for its innovation in saliva-based diagnostics for oral cancers. The company received funding of USD 1.76 million as an investment for progressing its research. Such developments are estimated to offer a favorable environment for the adoption of specimen collection cards during the forecast period.

Specimen Collection Cards Market Report Highlights:

• The specimen collection cards industry is expected to witness considerable growth due to rising emphasis on personalized medicines and cost-efficiency.
• The blood sample segment held the largest share in 2024, owing to an extensive rate of newborn screening in developed as well as developing countries.
• In 2024, the cotton & cellulose-based segment dominated the material segment owing to its operational superiority over other materials. Furthermore, the improved capacity of cotton & cellulose-based material for sample storage and integrity also drives its growth.
• The Whatman 903 product segment dominated the market in 2024 owing to its adoption in various government initiatives and research studies. Moreover, the extensive geographical presence of the company is also playing a major role in dominating market share.
• The newborn screening segment dominated the application segment in 2024. The favorable regulatory environment for newborn screening in several countries is contributing to the segment growth.
• The offline segment dominated the market in 2024 owing to convenient access. The online segment is estimated to register the fastest CAGR due to technological advancements.
• The hospital and clinics end-use segment held the major market share in 2024 due to its substantial adoption.
• North America dominated the market in 2024 due to the presence of key players and rising support from the government.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type of specimen
  • 1.2.2. Material
  • 1.2.3. Product
  • 1.2.4. Application
  • 1.2.5. Distribution channel
  • 1.2.6. End-use
  • 1.2.7. Regional scope
  • 1.2.8. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type of specimen outlook
  • 2.2.2. Material outlook
  • 2.2.3. Product outlook
  • 2.2.4. Application outlook
  • 2.2.5. Distribution channel outlook
  • 2.2.6. End-use outlook
  • 2.2.7. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Specimen Collection Cards Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rise of forensic to toxicology applications
    • 3.2.1.2. Growing Focus on personalized medicine and genetic testing
    • 3.2.1.3. Increasing awareness and adoption of point-of-care testing
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Challenges related to sample integrity and storage
    • 3.2.2.2. High initial setup costs and infrastructure requirements
• 3.3. Specimen Collection Cards Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Specimen Collection Cards Market: Type of Specimen Estimates & Trend Analysis

• 4.1. Type of Specimen Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Specimen Collection Cards Market by Type of Specimen Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Blood
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 4.4.2. Saliva
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Urine
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Buccal cells
    • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Specimen Collection Cards Market: Material Estimates & Trend Analysis

• 5.1. Material Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Specimen Collection Cards Market by Material Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Cotton & Cellulose-based
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 5.4.2. Fiber-based
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Others
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Specimen Collection Cards Market: Product Estimates & Trend Analysis

• 6.1. Product Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Specimen Collection Cards Market by Product Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Whatman 903
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.4.2. Ahlstrom 226
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. FTA
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Others
    • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Specimen Collection Cards Market: Application Estimates & Trend Analysis

• 7.1. Application Market Share, 2024 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Specimen Collection Cards Market by Application Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4.1. New Born Screening (NBS)
    • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 7.4.2. Infectious Diseases Testing
    • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Therapeutic Drug Monitoring
    • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Forensics
    • 7.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Research
    • 7.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Wellbeing/Health Monitoring
    • 7.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Others
    • 7.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Specimen Collection Cards Market: Distribution Channel Estimates & Trend Analysis

• 8.1. Distribution Channel Market Share, 2024 & 2030
• 8.2. Segment Dashboard
• 8.3. Global Specimen Collection Cards Market by Distribution Channel Outlook
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.4.1. Online
    • 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 8.4.2. Offline
    • 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Specimen Collection Cards Market: End Use Estimates & Trend Analysis

• 9.1. End Use Market Share, 2024 & 2030
• 9.2. Segment Dashboard
• 9.3. Global Specimen Collection Cards Market by End Use Outlook
• 9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 9.4.1. Hospitals & Clinics
    • 9.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 9.4.2. Diagnostic Laboratories
    • 9.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.3. Others
    • 9.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Specimen Collection Cards Market: Regional Estimates & Trend Analysis

• 10.1. Regional Market Share Analysis, 2024 & 2030
• 10.2. Regional Market Dashboard
• 10.3. Global Regional Market Snapshot
• 10.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 10.5. North America
  • 10.5.1. U.S.
    • 10.5.1.1. Key country dynamics
    • 10.5.1.2. Regulatory framework/ reimbursement structure
    • 10.5.1.3. Competitive scenario
    • 10.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.2. Canada
    • 10.5.2.1. Key country dynamics
    • 10.5.2.2. Regulatory framework/ reimbursement structure
    • 10.5.2.3. Competitive scenario
    • 10.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.3. Mexico
    • 10.5.3.1. Key country dynamics
    • 10.5.3.2. Regulatory framework/ reimbursement structure
    • 10.5.3.3. Competitive scenario
    • 10.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
• 10.6. Europe
  • 10.6.1. UK
    • 10.6.1.1. Key country dynamics
    • 10.6.1.2. Regulatory framework/ reimbursement structure
    • 10.6.1.3. Competitive scenario
    • 10.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.6.2. Germany
    • 10.6.2.1. Key country dynamics
    • 10.6.2.2. Regulatory framework/ reimbursement structure
    • 10.6.2.3. Competitive scenario
    • 10.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.6.3. France
    • 10.6.3.1. Key country dynamics
    • 10.6.3.2. Regulatory framework/ reimbursement structure
    • 10.6.3.3. Competitive scenario
    • 10.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.6.4. Italy
    • 10.6.4.1. Key country dynamics
    • 10.6.4.2. Regulatory framework/ reimbursement structure
    • 10.6.4.3. Competitive scenario
    • 10.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.6.5. Spain
    • 10.6.5.1. Key country dynamics
    • 10.6.5.2. Regulatory framework/ reimbursement structure
    • 10.6.5.3. Competitive scenario
    • 10.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.6.6. Norway
    • 10.6.6.1. Key country dynamics
    • 10.6.6.2. Regulatory framework/ reimbursement structure
    • 10.6.6.3. Competitive scenario
    • 10.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.6.7. Sweden
    • 10.6.7.1. Key country dynamics
    • 10.6.7.2. Regulatory framework/ reimbursement structure
    • 10.6.7.3. Competitive scenario
    • 10.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.6.8. Denmark
    • 10.6.8.1. Key country dynamics
    • 10.6.8.2. Regulatory framework/ reimbursement structure
    • 10.6.8.3. Competitive scenario
    • 10.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 10.7. Asia Pacific
  • 10.7.1. Japan
    • 10.7.1.1. Key country dynamics
    • 10.7.1.2. Regulatory framework/ reimbursement structure
    • 10.7.1.3. Competitive scenario
    • 10.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.2. China
    • 10.7.2.1. Key country dynamics
    • 10.7.2.2. Regulatory framework/ reimbursement structure
    • 10.7.2.3. Competitive scenario
    • 10.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.3. India
    • 10.7.3.1. Key country dynamics
    • 10.7.3.2. Regulatory framework/ reimbursement structure
    • 10.7.3.3. Competitive scenario
    • 10.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.4. Australia
    • 10.7.4.1. Key country dynamics
    • 10.7.4.2. Regulatory framework/ reimbursement structure
    • 10.7.4.3. Competitive scenario
    • 10.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.5. South Korea
    • 10.7.5.1. Key country dynamics
    • 10.7.5.2. Regulatory framework/ reimbursement structure
    • 10.7.5.3. Competitive scenario
    • 10.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.6. Thailand
    • 10.7.6.1. Key country dynamics
    • 10.7.6.2. Regulatory framework/ reimbursement structure
    • 10.7.6.3. Competitive scenario
    • 10.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 10.8. Latin America
  • 10.8.1. Brazil
    • 10.8.1.1. Key country dynamics
    • 10.8.1.2. Regulatory framework/ reimbursement structure
    • 10.8.1.3. Competitive scenario
    • 10.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.8.2. Argentina
    • 10.8.2.1. Key country dynamics
    • 10.8.2.2. Regulatory framework/ reimbursement structure
    • 10.8.2.3. Competitive scenario
    • 10.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 10.9. MEA
  • 10.9.1. South Africa
    • 10.9.1.1. Key country dynamics
    • 10.9.1.2. Regulatory framework/ reimbursement structure
    • 10.9.1.3. Competitive scenario
    • 10.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.9.2. Saudi Arabia
    • 10.9.2.1. Key country dynamics
    • 10.9.2.2. Regulatory framework/ reimbursement structure
    • 10.9.2.3. Competitive scenario
    • 10.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.9.3. UAE
    • 10.9.3.1. Key country dynamics
    • 10.9.3.2. Regulatory framework/ reimbursement structure
    • 10.9.3.3. Competitive scenario
    • 10.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.9.4. Kuwait
    • 10.9.4.1. Key country dynamics
    • 10.9.4.2. Regulatory framework/ reimbursement structure
    • 10.9.4.3. Competitive scenario
    • 10.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Recent Developments & Impact Analysis, By Key Market Participants
• 11.2. Company/Competition Categorization
• 11.3. Vendor Landscape
  • 11.3.1. Key company market share analysis, 2024
  • 11.3.2. QIAGEN
    • 11.3.2.1. Company overview
    • 11.3.2.2. Financial performance
    • 11.3.2.3. Product benchmarking
    • 11.3.2.4. Strategic initiatives
  • 11.3.3. PerkinElmer, Inc
    • 11.3.3.1. Company overview
    • 11.3.3.2. Financial performance
    • 11.3.3.3. Product benchmarking
    • 11.3.3.4. Strategic initiatives
  • 11.3.4. DBS System SA
    • 11.3.4.1. Company overview
    • 11.3.4.2. Financial performance
    • 11.3.4.3. Product benchmarking
    • 11.3.4.4. Strategic initiatives
  • 11.3.5. Danaher Corporation
    • 11.3.5.1. Company overview
    • 11.3.5.2. Financial performance
    • 11.3.5.3. Product benchmarking
    • 11.3.5.4. Strategic initiatives
  • 11.3.6. Eastern Business Forms, Inc
    • 11.3.6.1. Company overview
    • 11.3.6.2. Financial performance
    • 11.3.6.3. Product benchmarking
    • 11.3.6.4. Strategic initiatives
  • 11.3.7. Ahlstrom
    • 11.3.7.1. Company overview
    • 11.3.7.2. Financial performance
    • 11.3.7.3. Product benchmarking
    • 11.3.7.4. Strategic initiatives
  • 11.3.8. ARCHIMED Life Science GmbH
    • 11.3.8.1. Company overview
    • 11.3.8.2. Financial performance
    • 11.3.8.3. Product benchmarking
    • 11.3.8.4. Strategic initiatives
  • 11.3.9. GenTegra LLC
    • 11.3.9.1. Company overview
    • 11.3.9.2. Financial performance
    • 11.3.9.3. Product benchmarking
    • 11.3.9.4. Strategic initiatives
  • 11.3.10. FortiusBio
    • 11.3.10.1. Company overview
    • 11.3.10.2. Financial performance
    • 11.3.10.3. Product benchmarking
    • 11.3.10.4. Strategic initiatives
  • 11.3.11. CENTOGENE N.V.
    • 11.3.11.1. Company overview
    • 11.3.11.2. Financial performance
    • 11.3.11.3. Product benchmarking
    • 11.3.11.4. Strategic initiatives